What Myomo Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 13 |
| Sells | 3 | 6 |
| Total trades | 17 | 54 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 773,746 | 1,672,624 |
| Disposed | 120,803 | 306,839 |
| Net activity | +652,943 | +1,365,785 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Henry David A | Chief Financial Officer | Oct 13 | Grant / award · A | +51,250 | — | — | 549,862 |
| Kovelman Harry | Chief Medical Officer | Oct 13 | Grant / award · A | +32,500 | — | — | 122,389 |
| Gudonis Paul R | Chief Executive Officer | Oct 13 | Grant / award · A | +71,250 | — | — | 1,514,292 |
| Henry David A | Chief Financial Officer | Oct 12 | Withheld — tax / exercise cost · F | −3,133 | $1.37 | −$4.29K | 498,612 |
| McClure Mary-Katherine Hale | Chief Commericial Officer | Oct 12 | Grant / award · A | +275,000 | — | — | 275,000 |
| Gudonis Paul R | Chief Executive Officer | Oct 09 | Grant / award · A | +8,363 | — | — | 1,443,042 |
| Henry David A | Chief Financial Officer | Oct 09 | Grant / award · A | +6,272 | — | — | 501,745 |
| Kovelman Harry | Chief Medical Officer | Sep 11 | Open-market sale · S | −15,844 | $1.27 | −$20.1K | 89,889 |
| Morris Milton Mayo | Director | Sep 02 | Open-market sale · S | −15,000 | $1.41 | −$21.2K | 208,391 |
| Kovelman Harry | Chief Medical Officer | Aug 20 | Open-market sale · S | −17,500 | $1.73 | −$30.3K | 105,733 |
| Henry David A | Chief Financial Officer | Aug 07 | Withheld — tax / exercise cost · F | −25,310 | $1.42 | −$35.9K | 470,163 |
| Henry David A | Chief Financial Officer | Aug 07 | Grant / award · A | +68,644 | — | — | 495,473 |
| Kovelman Harry | Chief Medical Officer | Aug 07 | Withheld — tax / exercise cost · F | −22,457 | $1.42 | −$31.9K | 123,233 |
| Kovelman Harry | Chief Medical Officer | Aug 07 | Grant / award · A | +55,149 | — | — | 145,690 |
| Gudonis Paul R | Chief Executive Officer | Aug 07 | Grant / award · A | +146,909 | — | — | 1,434,679 |
| Mitchell Micah | Chief Commercial Officer | Aug 07 | Withheld — tax / exercise cost · F | −21,559 | $1.42 | −$30.6K | 130,738 |
| Mitchell Micah | Chief Commercial Officer | Aug 07 | Grant / award · A | +58,409 | — | — | 152,297 |
| Henry David A | Chief Financial Officer | Jul 13 | Withheld — tax / exercise cost · F | −5,166 | $1.09 | −$5.63K | 426,829 |
| Henry David A | Chief Financial Officer | Jul 10 | Grant / award · A | +7,840 | — | — | 431,995 |
| Gudonis Paul R | Chief Executive Officer | Jul 10 | Grant / award · A | +10,454 | — | — | 1,287,770 |
Loading...
